Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the Hepatitis Diagnostic Tests market right now?

The market size for hepatitis diagnostic tests has seen robust growth lately. The market is forecasted to expand from $4.64 billion in 2024 to $4.95 billion in 2025, indicative of a compound annual growth rate (CAGR) of 6.5%. Significant factors that have contributed to this growth during the historic period include the globalization of healthcare, government interventions, high disease prevalence, improved blood safety protocols, and public health initiatives.

How fast Is the hepatitis diagnostic tests market expected to grow, and what’s its future value?

The market for hepatitis diagnostic tests is anticipated to experience robust growth in the upcoming years, with projections indicating an increase to $6.24 billion in 2029, paralleling a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this predicted growth during the forecast period comprise of global health safety issues, population expansion and urban development, customized testing methods, focus on eradication initiatives, and rise in healthcare expenditure. Key trends foreseen during this period include progress in testing techniques, multi-testing for various hepatitis viruses, the incorporation of molecular diagnostics, digital health solutions, and strategic associations and partnerships.

Get your hepatitis diagnostic tests market report here!

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

What are the leading drivers of growth in the hepatitis diagnostic tests market?

The anticipated growth of the hepatitis diagnostic test market is majorly attributed to the increasing number of blood transfusions and donations. The process of blood transfusion and donation are inherently linked, involving voluntary blood donation by individuals which is later tested, collected and given to patients requiring additional blood due to various medical urgencies like surgeries, accidents, or illnesses. Hepatitis diagnostic tests play a pivotal role in ensuring a thorough screening of blood prior to donation or transfusion to safeguard the patients’ health. For example, as per the Royal College of Pathologists, a UK-based organization, in August 2023, blood transfusion emerged as the most common procedure for hospitalized patients. With close to two million blood components distributed and transfused annually in England, it is a procedure costing over £300 ($390.69) million. Hence, the escalating number of blood transfusions and donations is fostering the growth of the hepatitis diagnostic test market.

Hepatitis Diagnostic Tests Market Driver: Increased Hepatitis Incidence Spurs Hepatitis Diagnostic Tests Market Growth

What are the key segments defining the hepatitis diagnostic tests market?

The hepatitis diagnostic tests market covered in this report is segmented –

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies

3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users

Subsegments:

1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)

2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)

3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13153&type=smp

Who are the key players steering the development of the hepatitis diagnostic tests market?

Major companies operating in the hepatitis diagnostic tests market report are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech PLC, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

What emerging trends are influencing the growth of the hepatitis diagnostic tests market?

Leading corporations in the hepatitis diagnostic test market are focusing on the creation of novel automated immunoassays, such as Elecsys HCV Duo, in order to provide dependable customer service. Automated immunoassays like Elecsys HCV Duo utilize automation systems and specialized tools to execute every step of the immunoassay process, which includes handling samples, mixing reagents, incubation, detection, and result computation. For example, in July 2023, Roche Diagnostics India, a biotech research firm based in India, introduced Elecsys HCV Duo. This is the first fully automated immunoassay that is commercially available in India, allowing for independent and simultaneous measurement of the hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. This technology simplifies the diagnostic algorithm by enabling single specimen testing, reducing the necessity for additional tests that would require multiple visits, and potentially decreasing the testing load on the healthcare system.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13153

Which regions are most influential in expanding the hepatitis diagnostic tests market?

North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Viral Hepatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Hepatitis Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis B Virus (HBV) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: